Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques - 1 Mar 2018

Kuang Shaosong, Yang Lin, Rao Ziliang, Zhong Zhiyong, Li Jinfeng, Zhong Haichao, Dai Lulu, Tang Xiaojiang

Abstract excerpt

BACKGROUND: Parkinson's disease (PD) is a degenerative disorder of the central nervous system mainly affecting the motor system. Presently, there is no effective and safe drug to treat patients with PD. Ginkgo biloba extract (GBE), obtained from leaves of the Ginkgo biloba tree, is a complex mixture of ingredients primarily containing two active components: flavonoids and terpenoids. In this study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Dopamine Plasma Membrane Transport Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glutathione Peroxidase

Share to Locomotion

Share to Malondialdehyde

Share to Muscle Strength

Share to Plant Extracts

Share to Swimming

Source

Identifiers

PMID: 29506601
DOI: 10.1017/cjn.2017.268

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease.PMID 29506601Read ↗

Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson’s diseaseSemantic proximity Read ↗

α-Synuclein Transgenic Mice Reveal Compensatory Increases in Parkinson's Disease-Associated Proteins DJ-1 and Parkin and Have Enhanced α-Synuclein and PINK1 Levels After Rotenone TreatmentSemantic proximity Read ↗

Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells.Semantic proximity Read ↗

Gardenin A improves cognitive and motor function in A53T-α-syn miceSemantic proximity Read ↗

Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.Semantic proximity Read ↗

Protective Effects of Coptis chinensis Rhizome Extract and Its Constituents (Berberine, Coptisine, and Palmatine) against α-Synuclein Neurotoxicity in Dopaminergic SH-SY5Y Cells.Semantic proximity Read ↗

Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson’s disease modelsSemantic proximity Read ↗

D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.Semantic proximity Read ↗

Sirt1/FoxO1-Associated MAO-A Upregulation Promotes Depressive-Like Behavior in Transgenic Mice Expressing Human A53T α-Synuclein.Semantic proximity Read ↗

Loss of GBA in zebrafish leads to dopaminergic neurodegeneration, but overexpression of α-synuclein does not further worsen degeneration.Semantic proximity Read ↗

Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model.Semantic proximity Read ↗

A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.